Literature DB >> 12031927

Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study.

Rodrigo Portugal, Rony Schaffel, Leandro Almeida, Nelson Spector, Marcio Nucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12031927

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplantation for Oncohematological Malignancies.

Authors:  Adrián Sánchez-Montalvá; Fernando Salvador; Isabel Ruiz-Camps; Pere Barba; David Valcárcel; Elena Sulleiro; Enrique Sanz-García; Israel Molina
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

2.  Case Report: A Case of Recurrent Strongyloides stercoralis Colitis in a Patient with Multiple Myeloma.

Authors:  Keith Glenn; David A Lindholm; Gregory Meis; Luisa Watts; Nicholas Conger
Journal:  Am J Trop Med Hyg       Date:  2017-11       Impact factor: 2.345

3.  Thiabendazole inhibits ubiquinone reduction activity of mitochondrial respiratory complex II via a water molecule mediated binding feature.

Authors:  Qiangjun Zhou; Yujia Zhai; Jizhong Lou; Man Liu; Xiaoyun Pang; Fei Sun
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

Review 4.  Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents.

Authors:  Mohammed F Arshad; Aftab Alam; Abdullah Ayed Alshammari; Mohammed Bader Alhazza; Ibrahim Mohammed Alzimam; Md Anish Alam; Gulam Mustafa; Md Salahuddin Ansari; Abdulelah M Alotaibi; Abdullah A Alotaibi; Suresh Kumar; Syed Mohammed Basheeruddin Asdaq; Mohd Imran; Pran Kishore Deb; Katharigatta N Venugopala; Shahamah Jomah
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

Review 5.  Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?

Authors:  Yibin Xu; Ding Xue; Armand Bankhead; Nouri Neamati
Journal:  J Med Chem       Date:  2020-10-26       Impact factor: 8.039

Review 6.  Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.

Authors:  Cesar Henriquez-Camacho; Eduardo Gotuzzo; Juan Echevarria; A Clinton White; Angelica Terashima; Frine Samalvides; José A Pérez-Molina; Maria N Plana
Journal:  Cochrane Database Syst Rev       Date:  2016-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.